Welcome to MaineLifeScience.com

This network addresses the growing informational and service needs of companies, patients, educators and others in their respective states while providing clients the opportunity to cost effectively advertise their job openings, events, facility availability and other services at the state level, regionally or nationwide. We welcome your comments, suggestions and requests for informational content and supporting services.

Learn About Maine's BioHistory

Through Maine BioHistory, you can learn about the scientists, institutions, political leaders, and significant events that have shaped and are still shaping the biotechnology, medical device and life science industries in the state of Maine.

Local News...

Free News Release Posting & Archiving Service


• Insecticide Movento(R) approved in United States and Canada  The new insecticidal active ingredient spirotetramat from Bayer CropScience has been granted regulatory approval in the strategically important markets in the United States and Canada. Spirotetramat will be marketed worldwide under the brand name Movento(R).
  Bayer  July 03, 2008  
  
  
• Wyeth and Progenics receive approval from European Commission for RELISTOR  Wyeth Pharmaceuticals, a division of Wyeth, and Progenics Pharmaceuticals announced that the companies have received marketing approval for RELISTOR(TM) (methylnaltrexone bromide) subcutaneous injection from the European Commission.
  Progenics Pharmaceuticals, Inc.  July 03, 2008  
  
  
• Bayer HealthCare acquires hematology development portfolio featuring MAXY-VII from Maxygen  Bayer HealthCare is expanding its commitment to hemophilia with the acquisition of Maxygen's hemophilia program assets, including a next-generation recombinant Factor VIIa protein known as MAXY-VII. The lead therapeutic candidate is expected to enter Phase 1 clinical testing in 3Q 2008.
  Bayer  July 02, 2008  
  
  
• Thermo Fisher Scientific acquires Open Biosystems, creating unmatched RNAi platform  Thermo Fisher Scientific announced that it has acquired Open Biosystems, a provider of RNA interference (RNAi), gene expression and protein detection products for life science research and drug discovery and development. The acquisition expands the company's leadership position in the RNAi field.
  Thermo Fisher Scientific Inc.  July 02, 2008  
  
  
• Cubist to promote in the U.S. AstraZeneca's broad spectrum antibiotic, MERREM I.V.  Cubist Pharmaceuticals announced that it has signed an exclusive agreement with AstraZeneca to promote and provide other support in the United States for MERREM(R) I.V. (meropenem for injection), an established broad spectrum (carbapenem class) I.V. antibiotic.
  Cubist Pharmaceuticals, Inc.  July 02, 2008  
  
  

More... | Submit News Release | National News

New Job Postings...

Free Job Posting Trial Offer

• Quality Engineer AlloSource (CO)
• Machinist/Fabricator AlloSource (CO)
• Maintenance Engineer AlloSource (CO)
• Senior Application Specialist (biochemistry analyzer product line) Mindray Medical USA Corp. (WA)
• Research Technician II Benaroya Research Institute (WA)

More... | Job Advertising... | About Job Postings...

New Facilities Available...

ATC clean room constructors...validation guaranteed!

• Charter Construction Lab Building -- Seattle, WA
• Icogenex Biotech Incubator -- Seattle, WA
• Syntrix Biosystems Start-up Lab Space -- Auburn, WA
• University of Iowa Oakdale Research Park Biotech Building -- Coralville, IA
• University of Iowa Oakdale Research Park BioVentures Center -- Coralville, IA

More... | Facility Advertising...

Upcoming Events...

Free Event Posting Service

• 07/14/2008: AUTM Central Region Meeting
• 07/14/2008: Trial Design Innovation Conference
• 07/14/2008: AUTM Central Region Meeting
• 07/16/2008: MIT Enterprise Forum: Intellectual Property Forum
• 07/17/2008: CURE Biotech Summer Cookout

More... | Submit Event | Event Advertising...